Mivebresib T3712
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Mivebresib, also known as ABBV-075, is a potent BET inhibitor (bromodomain (BRD)-containing protein) with potential antineoplastic activity. Upon administration, the bromodomain inhibitor ABBV-075 binds to the acetyl-lysine binding site in the BRD of cert
CAS nr:
1445993-26-9
Purity:
98%
Molecular Weight:
459,11
SMILES:
C(C)S(=O)(=O)Nc1cc(c(cc1)Oc1c(cc(cc1)F)F)c1c2c(c(=O)n(c1)C)[nH]cc2
Formula:
C22H19F2N3O4S
Pathway:
Chromatin/Epigenetic,Apoptosis
Target:
Epigenetic Reader Domain,Apoptosis
